| Financial Year |
March 31 2023 |
| Monetary Funds |
211,025,619.32 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
61,959,812.86 |
| Accounts Receivable |
950,758,501.66 |
| Advances to Suppliers |
139,759,967.74 |
| Other Receivables |
47,769,489.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
100,576,116.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,466,820.21 |
| Total Current Assets |
1,612,010,911.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
43,796,571.08 |
| Investment Properties |
43,506,003.74 |
| Fixed Assetes |
1,025,925,785.78 |
| Under-construction Projects |
415,028,841.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
181,079,303.45 |
| R&D expenses |
-- |
| Goodwill |
670,533,744.42 |
| Long-Term Deferred and Prepaid Expenses |
62,934,005.03 |
| Deferred Income Tax Assets |
30,058,438.57 |
| Other Non-Current Assets |
9,515,704.78 |
| Sub-Total of Non-Current Assets |
2,773,287,889.57 |
| Total Assets |
4,385,298,800.63 |
| Short-Term Loans |
454,326,300.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
194,549,910.97 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
40,843,880.66 |
| Taxes Payable |
38,471,304.94 |
| Interest Payable |
-- |
| Dividend Payable |
19,447,751.01 |
| Other payables |
193,258,735.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
56,955,183.32 |
| Other Current Liabilities |
40,892,006.72 |
| Sub-Total of Current Liabilities |
1,233,077,393.87 |
| Long-term Loans |
443,540,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
21,748,899.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
781,007,317.46 |
| Total Liabilities |
2,014,084,711.33 |
| Paid-In Capital(Or Share Stock) |
729,518,079.00 |
| Capital Surplus |
127,877,332.17 |
| Surplus Reserve |
130,218,686.28 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
752,371,169.62 |
| Minority Stockholder's Interest |
609,820,861.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,761,393,227.55 |
| Owner's Equity（Stockholder's Equity） |
2,371,214,089.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,385,298,800.63 |
